India, April 7 -- BioLife Solutions, Inc. (BLFS), a US-based provider of bioproduction products and services for the cell and gene therapy - CGT market, announced the acquisition of PanTHERA CryoSolutions, Inc., a company specializing in innovative cryopreservation solutions based on proprietary Ice Recrystallization Inhibitor - IRI technology.
This acquisition strengthens BioLife's position in the biopreservation market by expanding its product portfolio and enhancing its scientific capabilities.
PanTHERA has developed and launched its first-generation IRI technology and is working on next-generation molecules designed to complement BioLife's cryopreservation products. These formulations are expected to launch within 18 months and offer ...